Immunotherapy
Head and neck melanoma associated with more adverse prognostic features
Researchers confirmed that head and neck melanomas have distinct biological characteristics that make it more adverse to patients yet more responsive to immunotherapy, according to a study.
Pembrolizumab regimen extends OS in triple-negative breast cancer
Use of pembrolizumab with neoadjuvant chemotherapy and as monotherapy in the adjuvant setting extended OS for patients with early-stage triple-negative breast cancer, according to results from the randomized phase 3 KEYNOTE-522 trial.
Prostate Cancer updates: Test identifies aggressive disease, diet affects progression risk
National Prostate Cancer Awareness Month is observed every September.
FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.
Keto diet plus experimental drug may shrink pancreatic tumors
The combination of a ketogenic diet and an experimental MNK inhibitor may be able to shrink pancreatic cancer tumors, according to preliminary study findings.
Trial to assess personalized vaccine for aggressive brain tumors
A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.
Risk for second primary malignancies no greater with CAR-T than other standard therapies
Patients who received chimeric antigen receptor T-cell therapy did not exhibit increased risk for second primary malignancies compared with those who received other standard treatments, according to a systematic review and meta-analysis.
Perioperative nivolumab improves outcomes in resectable NSCLC
Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.
Conference to take ‘full-circle’ approach to evidence-based integrative oncology
City of Hope will host Society for Integrative Oncology’s 21st International Conference from Oct. 25-27.
Q&A: How physicians can gear up for peak asthma month in September
As fall draws near, so does the season for viruses and environmental allergens, which can trigger asthma. Experts say that with children returning to school and the season changing, allergists can expect to see an increase in patients.